⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1075649 | 0.83 | AKR1C2 (0.48) | — | |
| SCHEMBL1076677 | 0.83 | — | — | |
| SCHEMBL14075397 | 0.74 | CYP2C9 (0.60) | — | |
| SCHEMBL10024300 | 0.74 | — | — | |
| SCHEMBL14075366 | 0.73 | CYP2C9 (0.56) | — | |
| SCHEMBL894697 | 0.73 | — | — | |
| SCHEMBL10024325 | 0.73 | — | — | |
| SCHEMBL10024303 | 0.73 | — | — | |
| SCHEMBL8609056 | 0.73 | — | — | |
| SCHEMBL27846663 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110071197-A1 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | BIOLIPOX AB (LV) | 2011-03-24 | — | — | US | disclosed |
| EP-2274280-A2 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | Biolipox AB (SE) | 2011-01-19 | — | — | EP | disclosed |
| WO-2009127822-A2 | BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS | BIOLIPOX AB (SE) | 2009-10-22 | — | — | WO | disclosed |